Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of NVP-2102 vs NVP-2102-R in Healthy Subjects
NCT05023031Phase 1Completed
- Sponsor
- NVP Healthcare Co., Ltd.
- Start
- Oct 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of NVP-2102 in hypertension (HTN) (2 arms), sponsored by NVP Healthcare Co., Ltd. Primary endpoints: Area under the plasma drug concentration-time curve (AUCt) and Maximum observed plasma concentration. Started Oct 2021; status: completed.
02
Drugs
NVP-2102
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05023031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05023031.